AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
17min chapter
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Business Trip
Navigating Psychedelic Therapy's Future
This chapter examines the implications of recent FDA advisory decisions affecting MDMA's therapeutic approval and its impact on the psychedelic therapy market. It highlights concerns regarding finances for companies and clinics, discusses evolving clinical trial methodologies, and the intersection of psychotherapy with drug treatments. The conversation further addresses investor confidence, the shift towards non-hallucinogenic therapies, and the potential involvement of larger pharmaceutical companies in transforming mental health treatment.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode